GHK-Cu is a naturally occurring copper-binding tripeptide that has drawn growing interest in dermatology and wound-care research. As demand for peptide-based skin treatments keeps climbing in 2026, it's worth separating what the science actually demonstrates from what's still speculative. Here's a look at what GHK-Cu is, what the current research shows, where the evidence runs out, and why sourcing and purity matter more than ever for anyone studying this compound.
DSIP in 2026: What the Research Actually Shows About the "Sleep Peptide" Trend
Delta sleep-inducing peptide, or DSIP, has become one of the more talked-about compounds in 2026's sleep-and-recovery corner of the peptide world. Interest has outpaced the science, though, and much of what circulates online blurs decades-old animal data with modern marketing claims. Here's a clear look at what DSIP actually is, what the current research does and doesn't support, and why sourcing and purity matter for anyone studying this peptide.
What Is DSIP? Delta sleep-inducing peptide (DSIP) is a naturally occurring nonapeptide first isolated from the blood of rabbits during sleep research in the 1970s. Despite its name, DSIP's role in the body is still not fully understood: early researchers proposed it as an endogenous signal tied to slow-wave (delta) sleep, but later work found it circulating at levels that don't consistently track with sleep stages. In 2026, DSIP has resurfaced in wellness and biohacking circles as part of a broader wave of interest in peptides marketed for recovery, stress resilience, and sleep support, often alongside better-studied compounds like BPC-157 and Epithalon.
What the Research Shows
Most of what's known about DSIP comes from animal studies conducted decades ago. Early research in rabbits and rats linked the peptide to increased slow-wave sleep, altered stress-hormone secretion, and changes in pain thresholds under experimental conditions. Small human studies from the 1980s and 1990s explored DSIP for stress-related insomnia and alcohol-withdrawal symptoms, reporting mixed results. Renewed laboratory attention has revisited its interaction with the hypothalamic-pituitary-adrenal axis, but no large, well-controlled clinical trials have been conducted in recent decades to confirm or update these older findings.
Where the Evidence Is Still Limited
Despite decades of laboratory interest, DSIP has never been the subject of a large, modern randomized controlled trial in humans. Most of the enthusiasm driving its current popularity comes from anecdotal reports and extrapolation from old, small-scale studies rather than new data. Researchers still don't have a clear, agreed-upon mechanism for how the peptide might influence sleep architecture, and its behavior as an endogenous signal doesn't necessarily predict how it performs when studied as an exogenous compound. Until better-designed trials exist, claims about DSIP's effects on sleep or recovery should be treated as preliminary at best.
Why Purity and Sourcing Matter for DSIP Research
As a short, unmodified peptide, DSIP is prone to degradation from heat, light, and repeated freeze-thaw cycles, and reconstituted solutions can lose potency quickly if handled poorly. The renewed retail interest in DSIP has also drawn gray-market sellers who sell unverified powders labeled simply as "DSIP" with no confirmation of identity or concentration. For any lab studying this peptide, a third-party HPLC certificate of analysis confirming both purity and correct sequence identity is the only reliable way to know what's actually in a vial, especially for a compound with such thin clinical backing.
Frequently Asked Questions
What is DSIP studied for in research? DSIP is investigated mainly for its proposed role in sleep regulation, stress-hormone modulation, and pain-threshold changes, based largely on animal studies from the 1970s through the 1990s.
Is there strong human clinical evidence for DSIP? No. Existing human studies are small, decades old, and inconsistent. No large, modern randomized controlled trials have evaluated DSIP's effects in people.
Does DSIP require special handling? Yes. Like most short peptides, DSIP is sensitive to heat, light, and repeated freeze-thaw cycles, and should be reconstituted and stored according to validated laboratory protocols.
How can researchers verify DSIP purity? Request a third-party HPLC certificate of analysis from the supplier confirming both the peptide's identity and its purity percentage before using it in any study.









